#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Dent's disease Scedosporium infection Thrombotic microangiopathy Gastroenteropancreatic neuroendocrine tumour disease Pulmonary arterial hypertension Cluster headache Paraneoplastic neurological syndrome Neuroendocrine carcinoma metastatic Ewing's sarcoma metastatic Mitochondrial DNA depletion Ischaemic stroke Immunoglobulin G4 related disease Myelodysplastic syndrome Arrhythmia General anaesthesia More trials…
Learn about Rare Diseases

Pelizaeus-Merzbacher disease – Diagnostics Toxic epidermal necrolysis – Diagnostics Leiomyosarcoma metastatic – Life with Disease Small intestine leiomyosarcoma – Trials in Disease Osteosarcoma recurrent – Treatment Fabry’s disease Ewing’s sarcoma recurrent Bronchopulmonary dysplasia – Diagnostics Cholangitis sclerosing – Basic Information Bronchiolitis obliterans syndrome – Trials in Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Eik1003 Allo-647 Insulin Aspart Sabestomig Tumour Detection Rizolipase Rilvegostomig Vorinostat Sumatriptan Succinate 6QC-ICG Polydextrose Mk-1084 Dyp688 Donanemab Alnus Glutinosa Pollen Sodium Citrate Somatostatin Liquid Paraffin Lamivudine Zilovertamab Vedotin More therapies…

Learn about Your Condition

Methylmalonic acidaemia Hypoglycaemia Extra-osseous Ewing's sarcoma Abdominal pain Cardiac amyloidosis Kidney transplant rejection Hyperparathyroidism primary Major depression Renal disorder Prostate cancer metastatic Acute myocardial infarction Cervix carcinoma stage II Tonsillitis ROHHAD syndrome VEXAS syndrome More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Philadelphia positive acute lymphocytic leukaemia

Study of olverembatinib with chemotherapy versus standard therapy in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Recruiting

3 1 1 1
Investigated Diseases:
- Philadelphia positive acute lymphocytic leukaemia
- Acute lymphocytic leukaemia
Investigated Drugs:
+3
Study on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Not recruiting

3 1 1 1
Investigated Diseases:
- Philadelphia positive acute lymphocytic leukaemia
Investigated Drugs:
Study Comparing Ponatinib and Imatinib with Chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Not recruiting

3 1 1 1
Investigated Drugs:
- Imatinib
- Ponatinib

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Philadelphia positive acute lymphocytic leukaemia

Study of olverembatinib with chemotherapy versus standard therapy in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Study on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Study Comparing Ponatinib and Imatinib with Chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies